| Product Code: ETC067000 | Publication Date: Aug 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Non-Oncology Precision Medicine Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 China Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 China Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 China Non-Oncology Precision Medicine Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 China Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F |
4 China Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of precision medicine in non-oncology treatments in China |
4.2.2 Government support and initiatives promoting precision medicine research and development |
4.2.3 Growing prevalence of chronic diseases and genetic disorders requiring personalized treatment approaches |
4.3 Market Restraints |
4.3.1 High costs associated with precision medicine technologies and treatments |
4.3.2 Limited availability of skilled healthcare professionals trained in precision medicine techniques in China |
5 China Non-Oncology Precision Medicine Market Trends |
6 China Non-Oncology Precision Medicine Market, By Types |
6.1 China Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 China Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2018 - 2027F |
6.1.3 China Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2018 - 2027F |
6.1.4 China Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2018 - 2027F |
6.1.5 China Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2018 - 2027F |
6.1.6 China Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2018 - 2027F |
6.1.7 China Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 China Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 China Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2018 - 2027F |
6.2.3 China Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2018 - 2027F |
6.2.4 China Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2018 - 2027F |
7 China Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 China Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 China Non-Oncology Precision Medicine Market Imports from Major Countries |
8 China Non-Oncology Precision Medicine Market Key Performance Indicators |
8.1 Number of research collaborations between academic institutions, healthcare providers, and pharmaceutical companies in the field of non-oncology precision medicine |
8.2 Percentage increase in funding allocated by the Chinese government towards precision medicine initiatives |
8.3 Number of clinical trials and studies focusing on non-oncology precision medicine treatments in China |
8.4 Adoption rate of precision medicine technologies and tools by healthcare facilities and providers in China |
8.5 Patient outcomes and success rates of personalized treatment approaches in non-oncology precision medicine in China |
9 China Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 China Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 China Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F |
10 China Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 China Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2021 |
10.2 China Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here